Bioneer Corporation (KOSDAQ:064550)
South Korea · Delayed Price · Currency is KRW 6,090.00
0.00 (0.00%)
Jul 21, 2026, 2:50 PM KST
Bioneer Market Cap
Bioneer has a market cap or net worth of 157.18 billion as of July 20, 2026. Its market cap has decreased by -59.85% in one year.
Market Cap
157.18B
Enterprise Value
183.56B
Revenue
338.01B
Ranking
n/a
PE Ratio
n/a
Stock Price
6,090.00
ChartMarket Cap Chart
Since December 29, 2005, Bioneer's market cap has decreased from 157.77B to 157.18B, a decrease of -0.37%. That is a compound annual growth rate of -0.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 157.18B | -52.24% |
| Dec 30, 2025 | 329.08B | -32.36% |
| Dec 30, 2024 | 486.52B | -43.39% |
| Dec 28, 2023 | 859.48B | 13.27% |
| Dec 29, 2022 | 758.82B | -39.51% |
| Dec 30, 2021 | 1.25T | 181.19% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BINEX | 214.65B |
| EASY BIO,Inc. | 208.09B |
| GC Cell | 200.46B |
| Anterogen.Co.,Ltd. | 183.21B |
| HLB Therapeutics | 171.62B |
| JETEMA, | 165.93B |
| Helixmith | 160.93B |
| NeoImmuneTech | 134.86B |